These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 20225655)
1. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients. Uesawa Y; Motege E; Dai Y; Ishii K; Mohri K Pharmazie; 2010 Feb; 65(2):114-6. PubMed ID: 20225655 [TBL] [Abstract][Full Text] [Related]
2. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin. Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241 [TBL] [Abstract][Full Text] [Related]
3. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection. Sidhu-Malik NK; Kaplan AL J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408 [TBL] [Abstract][Full Text] [Related]
4. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between patient profile and feverishness developed during interferon-ribavirin combination therapy of chronic hepatitis C patients]. Motegi E; Uesawa Y; Dai Y; Ishii K; Mohri K Yakugaku Zasshi; 2008 Dec; 128(12):1803-10. PubMed ID: 19043300 [TBL] [Abstract][Full Text] [Related]
6. [Selection of therapy in patients with chronic hepatitis C showing features like autoimmune hepatitis]. Kakumu S Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):663-6. PubMed ID: 15359881 [No Abstract] [Full Text] [Related]
8. [Severe thrombocytopenia with probable autoimmune mechanism associated with interferon therapy in a patient with chronic hepatitis C]. Carnero-Fernández M; Pineda JR; Lite-Alvarez JM Gastroenterol Hepatol; 2006 May; 29(5):297-8. PubMed ID: 16733036 [TBL] [Abstract][Full Text] [Related]
9. Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Kim SK; Kim SR; Imoto S; Kim CW; Hayashi Y Turk J Gastroenterol; 2017 Jan; 28(1):75-76. PubMed ID: 28007686 [No Abstract] [Full Text] [Related]
10. [Complications in interferon therapy for chronic hepatitis C]. Arase Y Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854 [No Abstract] [Full Text] [Related]
12. [Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia]. Aizawa N; Nishiguchi S Nihon Rinsho; 2011 May; 69 Suppl 4():201-5. PubMed ID: 22096919 [No Abstract] [Full Text] [Related]
13. Bipolar disorder and interferon treatment: how to manage? Aalouane R; Hafidi H; Rammouz I Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):1002. PubMed ID: 23817449 [No Abstract] [Full Text] [Related]
14. [Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report]. Rao HY; Ma H; Wei L Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):631. PubMed ID: 20825725 [No Abstract] [Full Text] [Related]
15. [Clinical immunological effect of interferon in cases of influenza]. Volkova LV; Vorob'eva NN; Bondarenko AL; Sedel'nikova NA; Okishev MA Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):50-3. PubMed ID: 18283734 [TBL] [Abstract][Full Text] [Related]